The present disclosure pertains to methods and/or systems for making a SIPN and/or an IPN by physically mixing at least one vinyl functional thermoset with at least one thermoplastic resin. For example, a method of producing a resin composition comprising: mixing at least one vinyl functional thermoset resin with at least one thermoplastic resin wherein: the two resins are sufficiently miscible at a mixing viscosity of at least at least 5,000 cPs measured at the temperature of mixing and the mixing results in sufficient laminar flow such that a substantial portion of the resin mixture forms an IPN and/or a SIPN. The IPNs and/or SPINs formed have one or more superior properties over mixtures of the same resins.

A transparent plate includes a transparent substrate and an antifouling layer. A surface of the transparent substrate includes a fine projecting and recessed structure with a surface roughness of 2.0-100 nm. The antifouling layer includes fluorine, and at least a part of the antifouling layer is formed on a position of the fine projecting and recessed structure. A haze value of the transparent plate at the position of the fine projecting and recessed structure is 2% or less. A value of X defined by (S.sub.1S.sub.2)/(S.sub.3S.sub.2) is 0.5 or more, where S.sub.1, S.sub.2 and S.sub.3 are F-K line strengths of the transparent plate at the position of the fine projecting and recessed structure, a reference glass plate that does not include fluorine, and a reference aluminosilicate glass plate that includes fluorine of 2 wt %, respectively, and S.sub.1, S.sub.2 and S.sub.3 are measured by a fluorescent X-ray measurement device.

The invention provides methods for preparing a polymer-grafted and functionalized nonwoven membrane adapted for use in separation processes. The invention further provides so-formed membranes as well as improved separation methods utilizing the membranes. The polymer-grafted and functionalized nonwoven membranes are particularly formed utilizing thermal grafting. In particular, an acrylate or methacrylate polymer can be grafted onto a nonwoven web comprising a plurality of polymeric fibers to form a plurality of polymer segments covalently attached to the polymeric fibers. Thermal grafting particularly can comprise using a thermal initiator and exposing the nonwoven web to heat to initiate polymerization of the acrylate or methacrylate monomer. The grafted polymeric fibers can be functionalized to attach at least one functional group adapted for binding to a target molecule to the polymer segments of the grafted polymeric fibers.

Cure monitoring systems for and methods of monitoring polymerizable material to determine the degree of curing of the polymerizable material. A monitoring light source delivers visible monitoring light at one or more different visible wavelengths and a visible light detector detects the monitoring light diffusely reflected by the polymerizable material. The monitoring light has a wavelength of maximum emission (.sub.max-mon) that does not effectively induce polymerization of the polymerizable material. Change in intensity of the monitoring light reflected from the polymerizable material is used to determine when a selected degree of curing is reached in the polymerizable material.

A biocompatible, covalently cross-linked, polymer that is obtained by reacting an electrophilically activated polyoxazoline (EL-POX) with a nucleophilic cross-linking agent is disclosed. The EL-POX comprises m electrophilic groups; and the nucleophilic cross-linking agent comprises n nucleophilic groups, wherein the m electrophilic groups are capable of reacting with the n nucleophilic groups to form covalent bonds; wherein m2, n2 and m+n5; wherein at least one of the m electrophilic groups is a pendant electrophilic group and/or wherein m3; and wherein to the EL-POX comprises an excess amount of electrophilic groups relative to the amount of nucleophilic groups contained in the nucleophilic cross-linking agent. Biocompatible medical products and kits comprising the cross-linked POX-polymers are also disclosed.

A method for manufacturing a tire rubber composition includes kneading a rubber component, a silane coupling agent and a silica having a BET specific surface area of 210 m.sup.2/g or more, adding a vulcanization accelerator to a first kneaded material including the rubber component, silane coupling agent and silica, kneading a first resulting mixture including the rubber component, silane coupling agent, silica and vulcanization accelerator such that a second kneaded material including the rubber component, silane coupling agent, silica and vulcanization accelerator is obtained, adding a vulcanization agent to the second kneaded material including the rubber component, silane coupling agent, silica and vulcanization accelerator, and kneading a second resulting mixture including the rubber component, silane coupling agent, silica, vulcanization accelerator and vulcanization agent. The first kneaded material has a pH of 6.5 or less, and the second kneaded material has a pH of 8.0 or more.

An electronic device includes: a polymer film that is to melt at a predetermined temperature higher than a body temperature; at least one electronic component provided in the polymer film; and a first hydrophobic film provided on an opposite surface of the polymer film to a side of the polymer film to be attached to skin.

A biocompatible, covalently cross-linked, polymer that is obtained by reacting an electrophilically activated polyoxazoline (EL-PDX) with a nucleophilic cross-linking agent is disclosed. The EL-PDX comprises m electrophilic groups; and the nucleophilic cross-linking agent comprises n nucleophilic groups, wherein the m electrophilic groups are capable of reacting with the n nucleophilic groups to form covalent bonds; wherein m2, n2 and m+n5; wherein at least one of the m electrophilic groups is a pendant electrophilic group and/or wherein m3; and wherein the EL-PDX comprises an excess amount of electrophilic groups relative to the amount of nucleophilic groups contained in the nucleophilic cross-linking agent. Biocompatible medical products and kits comprising the cross-linked PDX-polymers are also disclosed.

The present invention relates to a ligand-containing conjugated microporous polymer, which is obtained by covalent coupling of a conjugated microporous polymer and a uranium complexing ligand. The conjugated microporous polymer comprises an aromatic ring and/or a heterocyclic ring. The uranium complexing ligand is selected from the group consisting of a compound with a group containing phosphorus, a compound with a group containing nitrogen, and a compound with a group containing sulfur. The invention further provides use of the ligand-containing conjugated microporous polymer as a uranium adsorbent. The ligand-containing conjugated microporous polymer the invention is capable of adsorbing the radioactive element uranium in strongly acidic and strong-radiation environments.

A display apparatus and a method of manufacturing a display apparatus, the apparatus including a substrate; a display on the substrate; and an encapsulation layer that seals the display, wherein the encapsulation layer includes a matrix including an organic material, and an inorganic material bonded to the organic material through functional groups of the organic material of the matrix, wherein the matrix includes an internal space adjacent to the organic material, the inorganic material being positioned in the internal space.